• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Anacor Pharmaceuticals, Inc. (ANAC)

    -NasdaqGM
    33.21 Up 0.19(0.58%) 4:00PM EST
    |After Hours : 33.21 0.00 (0.00%) 4:36PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 17,228   10,740   20,306  
    Cost of Revenue -   -   -  
    Gross Profit 17,228   10,740   20,306  
    Operating Expenses
    Research Development46,561  52,318  56,097  
    Selling General and Administrative20,650  11,614  10,552  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 92,517   (53,192) (46,343)
    Income from Continuing Operations
    Total Other Income/Expenses Net140,505  19  (205)
    Earnings Before Interest And Taxes90,522  (53,173)(46,548)
    Interest Expense4,051  2,914  1,396  
    Income Before Tax86,471  (56,087)(47,944)
    Income Tax Expense1,706   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops83,384  (56,087)(48,257)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 84,765   (56,087) (47,944)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 84,765   (56,087) (47,944)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.